Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G for Immunic, Inc. Common Stock, $0.0001 par value (IMUX).
- Disclosed ownership: 9.9%.
- Date of event: 30 Jun 2025.
Alyeska Investment Group, L.P. - 30 Jun 2025 SCHEDULE 13G Report for Immunic, Inc. Common Stock, $0.0001 par value (IMUX)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- IMUX
- Shares outstanding
- 95,817,535 shares
- Disclosed Ownership
- 9,485,936 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 17:38:14 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 9.9% ownership in Immunic, Inc. Common Stock, $0.0001 par value (IMUX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 17:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 9.9% | 9,485,936 | 0 | 9,485,936 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 9.9% | 9,485,936 | 0 | 9,485,936 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 9.9% | 9,485,936 | 0 | 9,485,936 | Anand Parekh | Anand Parekh | Self |